Minor Spliceosomal 65K/RNPC3 Interacts with ANKRD11 and Mediates HDAC3-Regulated Histone Deacetylation and Transcription.
Chen-Hui LiShao-Bo LiangQi-Wei HuangZhen-Zhen ZhouZhan DingNi LongKwang-Chon WiLiang LiXi-Ping JiangYu-Jie FanYong-Zhen XuPublished in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
RNA splicing is crucial in the multilayer regulatory networks for gene expression, making functional interactions with DNA- and other RNA-processing machineries in the nucleus. However, these established couplings are all major spliceosome-related; whether the minor spliceosome is involved remains unclear. Here, through affinity purification using Drosophila lysates, an interaction is identified between the minor spliceosomal 65K/RNPC3 and ANKRD11, a cofactor of histone deacetylase 3 (HDAC3). Using a CRISPR/Cas9 system, Deletion strains are constructed and found that both Dm65K Δ/Δ and Dmankrd11 Δ/Δ mutants have reduced histone deacetylation at Lys9 of histone H3 (H3K9) and Lys5 of histone H4 (H4K5) in their heads, exhibiting various neural-related defects. The 65K-ANKRD11 interaction is also conserved in human cells, and the HsANKRD11 middle-uncharacterized domain mediates Hs65K association with HDAC3. Cleavage under targets and tagmentation (CUT&Tag) assays revealed that HsANKRD11 is a bridging factor, which facilitates the synergistic common chromatin-binding of HDAC3 and Hs65K. Knockdown (KD) of HsANKRD11 simultaneously decreased their common binding, resulting in reduced deacetylation of nearby H3K9. Ultimately, this study demonstrates that expression changes of many genes caused by HsANKRD11-KD are due to the decreased common chromatin-binding of HDAC3 and Hs65K and subsequently reduced deacetylation of H3K9, illustrating a novel and conserved coupling mechanism that links the histone deacetylation with minor spliceosome for the regulation of gene expression.
Keyphrases
- histone deacetylase
- gene expression
- transcription factor
- dna methylation
- dna binding
- genome wide
- crispr cas
- binding protein
- dna damage
- genome wide identification
- poor prognosis
- escherichia coli
- metabolic syndrome
- single cell
- type diabetes
- drug delivery
- single molecule
- oxidative stress
- mass spectrometry
- circulating tumor cells
- ionic liquid